PP 8.1 – 00003 Optimization of the 5′ cap and untranslated regions enhances the immunogenicity of an mRNA-based therapeutic vaccine in SIV-infected rhesus macaques on ART
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2022-12-01
|
| Series: | Journal of Virus Eradication |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2055664022002199 |
| _version_ | 1828262854749323264 |
|---|---|
| author | W. Omange B. Varco-Merth A. Morenco M.T. Chaunzwa C. Nkoy D. Duell O. Fadeyi M. Medina S. Hoffmeister W. Goodwin R. Butler Z. Etaki H. Park J. Smedley M.K. Axhelm S. Hansen J. Lifson J. Gergen S. Rauch B. Petsch L.J. Picker A.A. Okoye |
| author_facet | W. Omange B. Varco-Merth A. Morenco M.T. Chaunzwa C. Nkoy D. Duell O. Fadeyi M. Medina S. Hoffmeister W. Goodwin R. Butler Z. Etaki H. Park J. Smedley M.K. Axhelm S. Hansen J. Lifson J. Gergen S. Rauch B. Petsch L.J. Picker A.A. Okoye |
| author_sort | W. Omange |
| collection | DOAJ |
| first_indexed | 2024-04-13T04:02:34Z |
| format | Article |
| id | doaj.art-b478cb703b5b473ea6702724b20b8a83 |
| institution | Directory Open Access Journal |
| issn | 2055-6640 |
| language | English |
| last_indexed | 2024-04-13T04:02:34Z |
| publishDate | 2022-12-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Journal of Virus Eradication |
| spelling | doaj.art-b478cb703b5b473ea6702724b20b8a832022-12-22T03:03:25ZengElsevierJournal of Virus Eradication2055-66402022-12-018100281PP 8.1 – 00003 Optimization of the 5′ cap and untranslated regions enhances the immunogenicity of an mRNA-based therapeutic vaccine in SIV-infected rhesus macaques on ARTW. Omange0B. Varco-Merth1A. Morenco2M.T. Chaunzwa3C. Nkoy4D. Duell5O. Fadeyi6M. Medina7S. Hoffmeister8W. Goodwin9R. Butler10Z. Etaki11H. Park12J. Smedley13M.K. Axhelm14S. Hansen15J. Lifson16J. Gergen17S. Rauch18B. Petsch19L.J. Picker20A.A. Okoye21Vaccine and Gene therapy Institute, Oregon Health and Science University, Beaverton, Oregon, USAVaccine and Gene therapy Institute, Oregon Health and Science University, Beaverton, Oregon, USA; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USAVaccine and Gene therapy Institute, Oregon Health and Science University, Beaverton, Oregon, USA; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USAVaccine and Gene therapy Institute, Oregon Health and Science University, Beaverton, Oregon, USA; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USAVaccine and Gene therapy Institute, Oregon Health and Science University, Beaverton, Oregon, USA; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USAVaccine and Gene therapy Institute, Oregon Health and Science University, Beaverton, Oregon, USA; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USAVaccine and Gene therapy Institute, Oregon Health and Science University, Beaverton, Oregon, USA; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USAVaccine and Gene therapy Institute, Oregon Health and Science University, Beaverton, Oregon, USA; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USAVaccine and Gene therapy Institute, Oregon Health and Science University, Beaverton, Oregon, USA; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USAVaccine and Gene therapy Institute, Oregon Health and Science University, Beaverton, Oregon, USA; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USAVaccine and Gene therapy Institute, Oregon Health and Science University, Beaverton, Oregon, USA; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USAVaccine and Gene therapy Institute, Oregon Health and Science University, Beaverton, Oregon, USA; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USAVaccine and Gene therapy Institute, Oregon Health and Science University, Beaverton, Oregon, USA; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USAOregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USAOregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USAVaccine and Gene therapy Institute, Oregon Health and Science University, Beaverton, Oregon, USA; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USAAIDS and Cancer Virus Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, USACureVac AG, Tübingen, GermanyCureVac AG, Tübingen, GermanyCureVac AG, Tübingen, GermanyVaccine and Gene therapy Institute, Oregon Health and Science University, Beaverton, Oregon, USA; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USAVaccine and Gene therapy Institute, Oregon Health and Science University, Beaverton, Oregon, USA; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USAhttp://www.sciencedirect.com/science/article/pii/S2055664022002199 |
| spellingShingle | W. Omange B. Varco-Merth A. Morenco M.T. Chaunzwa C. Nkoy D. Duell O. Fadeyi M. Medina S. Hoffmeister W. Goodwin R. Butler Z. Etaki H. Park J. Smedley M.K. Axhelm S. Hansen J. Lifson J. Gergen S. Rauch B. Petsch L.J. Picker A.A. Okoye PP 8.1 – 00003 Optimization of the 5′ cap and untranslated regions enhances the immunogenicity of an mRNA-based therapeutic vaccine in SIV-infected rhesus macaques on ART Journal of Virus Eradication |
| title | PP 8.1 – 00003 Optimization of the 5′ cap and untranslated regions enhances the immunogenicity of an mRNA-based therapeutic vaccine in SIV-infected rhesus macaques on ART |
| title_full | PP 8.1 – 00003 Optimization of the 5′ cap and untranslated regions enhances the immunogenicity of an mRNA-based therapeutic vaccine in SIV-infected rhesus macaques on ART |
| title_fullStr | PP 8.1 – 00003 Optimization of the 5′ cap and untranslated regions enhances the immunogenicity of an mRNA-based therapeutic vaccine in SIV-infected rhesus macaques on ART |
| title_full_unstemmed | PP 8.1 – 00003 Optimization of the 5′ cap and untranslated regions enhances the immunogenicity of an mRNA-based therapeutic vaccine in SIV-infected rhesus macaques on ART |
| title_short | PP 8.1 – 00003 Optimization of the 5′ cap and untranslated regions enhances the immunogenicity of an mRNA-based therapeutic vaccine in SIV-infected rhesus macaques on ART |
| title_sort | pp 8 1 00003 optimization of the 5 cap and untranslated regions enhances the immunogenicity of an mrna based therapeutic vaccine in siv infected rhesus macaques on art |
| url | http://www.sciencedirect.com/science/article/pii/S2055664022002199 |
| work_keys_str_mv | AT womange pp8100003optimizationofthe5capanduntranslatedregionsenhancestheimmunogenicityofanmrnabasedtherapeuticvaccineinsivinfectedrhesusmacaquesonart AT bvarcomerth pp8100003optimizationofthe5capanduntranslatedregionsenhancestheimmunogenicityofanmrnabasedtherapeuticvaccineinsivinfectedrhesusmacaquesonart AT amorenco pp8100003optimizationofthe5capanduntranslatedregionsenhancestheimmunogenicityofanmrnabasedtherapeuticvaccineinsivinfectedrhesusmacaquesonart AT mtchaunzwa pp8100003optimizationofthe5capanduntranslatedregionsenhancestheimmunogenicityofanmrnabasedtherapeuticvaccineinsivinfectedrhesusmacaquesonart AT cnkoy pp8100003optimizationofthe5capanduntranslatedregionsenhancestheimmunogenicityofanmrnabasedtherapeuticvaccineinsivinfectedrhesusmacaquesonart AT dduell pp8100003optimizationofthe5capanduntranslatedregionsenhancestheimmunogenicityofanmrnabasedtherapeuticvaccineinsivinfectedrhesusmacaquesonart AT ofadeyi pp8100003optimizationofthe5capanduntranslatedregionsenhancestheimmunogenicityofanmrnabasedtherapeuticvaccineinsivinfectedrhesusmacaquesonart AT mmedina pp8100003optimizationofthe5capanduntranslatedregionsenhancestheimmunogenicityofanmrnabasedtherapeuticvaccineinsivinfectedrhesusmacaquesonart AT shoffmeister pp8100003optimizationofthe5capanduntranslatedregionsenhancestheimmunogenicityofanmrnabasedtherapeuticvaccineinsivinfectedrhesusmacaquesonart AT wgoodwin pp8100003optimizationofthe5capanduntranslatedregionsenhancestheimmunogenicityofanmrnabasedtherapeuticvaccineinsivinfectedrhesusmacaquesonart AT rbutler pp8100003optimizationofthe5capanduntranslatedregionsenhancestheimmunogenicityofanmrnabasedtherapeuticvaccineinsivinfectedrhesusmacaquesonart AT zetaki pp8100003optimizationofthe5capanduntranslatedregionsenhancestheimmunogenicityofanmrnabasedtherapeuticvaccineinsivinfectedrhesusmacaquesonart AT hpark pp8100003optimizationofthe5capanduntranslatedregionsenhancestheimmunogenicityofanmrnabasedtherapeuticvaccineinsivinfectedrhesusmacaquesonart AT jsmedley pp8100003optimizationofthe5capanduntranslatedregionsenhancestheimmunogenicityofanmrnabasedtherapeuticvaccineinsivinfectedrhesusmacaquesonart AT mkaxhelm pp8100003optimizationofthe5capanduntranslatedregionsenhancestheimmunogenicityofanmrnabasedtherapeuticvaccineinsivinfectedrhesusmacaquesonart AT shansen pp8100003optimizationofthe5capanduntranslatedregionsenhancestheimmunogenicityofanmrnabasedtherapeuticvaccineinsivinfectedrhesusmacaquesonart AT jlifson pp8100003optimizationofthe5capanduntranslatedregionsenhancestheimmunogenicityofanmrnabasedtherapeuticvaccineinsivinfectedrhesusmacaquesonart AT jgergen pp8100003optimizationofthe5capanduntranslatedregionsenhancestheimmunogenicityofanmrnabasedtherapeuticvaccineinsivinfectedrhesusmacaquesonart AT srauch pp8100003optimizationofthe5capanduntranslatedregionsenhancestheimmunogenicityofanmrnabasedtherapeuticvaccineinsivinfectedrhesusmacaquesonart AT bpetsch pp8100003optimizationofthe5capanduntranslatedregionsenhancestheimmunogenicityofanmrnabasedtherapeuticvaccineinsivinfectedrhesusmacaquesonart AT ljpicker pp8100003optimizationofthe5capanduntranslatedregionsenhancestheimmunogenicityofanmrnabasedtherapeuticvaccineinsivinfectedrhesusmacaquesonart AT aaokoye pp8100003optimizationofthe5capanduntranslatedregionsenhancestheimmunogenicityofanmrnabasedtherapeuticvaccineinsivinfectedrhesusmacaquesonart |